FAM83D acts as an oncogene by regulating cell cycle progression via multiple pathways in synovial sarcoma: a potential novel downstream target oncogene of anlotinib
Article in Discover Oncology (March 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Article in Discover Oncology (March 2024)
Article in Biomedicine & Pharmacotherapy (March 2024)
Article in Breast Cancer Research (January 2024)